Literature DB >> 9288597

Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg.

M A Loriot1, P Marcellin, F Walker, N Boyer, C Degott, I Randrianatoavina, J P Benhamou, S Erlinger.   

Abstract

BACKGROUND/AIMS: The persistence of serum and liver hepatitis B virus (HBV) sequences in patients with chronic hepatitis B after loss of HBsAg has already been described. We have attempted to elucidate the significance of these HBV sequences after loss of HBsAg.
METHODS: Fifteen patients were studied. We looked for serum and liver HBV DNA, using polymerase chain reaction (PCR) with different sets of primers and in situ hybridization. The sedimentation velocity of serum HBV DNA was measured on a gradient of sucrose in two patients.
RESULTS: Serum HBV DNA was detected by PCR in four of the 14 patients tested at 0 months after loss of HBsAg, two patients remained HBV DNA positive until 12 months, and none was positive at 24 months. The sedimentation velocity of serum HBV DNA in sucrose was relatively similar to that of a chronic HBV carrier with active viral replication. Liver HBV DNA was demonstrated by PCR in all 15 patients and by in situ hybridization in six patients.
CONCLUSIONS: Our results show that: 1) HBV DNA may persist in the serum in a minority of patients and may be associated with circulating viral particles; 2) HBV DNA persists in the liver in all patients and its extrachromosomal localization was shown by in situ hybridization technique in some cases. These results suggest the persistence of low-level HBV replication after loss of HBsAg.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9288597     DOI: 10.1016/s0168-8278(97)80168-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  25 in total

Review 1.  The underlying mechanisms for the "isolated positivity for the hepatitis B surface antigen (HBsAg)" serological profile.

Authors:  Robério Amorim de Almeida Pondé
Journal:  Med Microbiol Immunol       Date:  2010-05-11       Impact factor: 3.402

2.  Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B.

Authors:  Konstantinos Tziomalos
Journal:  World J Hepatol       Date:  2010-03-27

3.  Identification of different states of hepatitis B virus infection with a quantitative PCR assay.

Authors:  H H Kessler; S Preininger; E Stelzl; E Daghofer; B I Santner; E Marth; H Lackner; R E Stauber
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 4.  Diagnosis and management of clinical and subclinical cobalamin deficiency: advances and controversies.

Authors:  Ralph Carmel; Mona Sarrai
Journal:  Curr Hematol Rep       Date:  2006-03

5.  In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection.

Authors:  Xiaonan Zhang; Wei Lu; Ye Zheng; Weixia Wang; Lu Bai; Liang Chen; Yanling Feng; Zhanqing Zhang; Zhenghong Yuan
Journal:  J Clin Invest       Date:  2016-02-22       Impact factor: 14.808

6.  Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.

Authors:  Chun-Jen Liu; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2011-06-14       Impact factor: 6.047

7.  The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review.

Authors:  Fabrizio Marcucci; Enea Spada; Alfonso Mele; Carmelo Antonio Caserta; Alessandro Pulsoni
Journal:  Am J Blood Res       Date:  2012-01-01

Review 8.  Managing hepatitis B coinfection in HIV-infected patients.

Authors:  Marion G Peters
Journal:  Curr HIV/AIDS Rep       Date:  2005-08       Impact factor: 5.071

Review 9.  Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc Testing.

Authors:  Antonella Esposito; Chiara Sabia; Carmela Iannone; Giovanni F Nicoletti; Linda Sommese; Claudio Napoli
Journal:  Transfus Med Hemother       Date:  2017-05-05       Impact factor: 3.747

10.  Clinical and virological characteristics post HBsAg seroclearance in hepatitis B virus carriers with hepatic steatosis versus those without.

Authors:  Chia-Ming Chu; Deng-Yn Lin; Yun-Fan Liaw
Journal:  Dig Dis Sci       Date:  2012-08-18       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.